G5D

4-({4-[(1S,4S)-5-(cyanoacetyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-2-yl}amino)-N-ethylbenzamide

Created:	2018-05-04
Last modified:	2018-08-29

Find Related PDB Entry
1 entries where G5D is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	2
Bond Count	56
Aromatic Bond Count	12

2D diagram of G5D

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-({4-[(1S,4S)-5-(cyanoacetyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-2-yl}amino)-N-ethylbenzamide
Systematic Name (OpenEye OEToolkits)	4-[[4-[(1~{S},4~{S})-5-(2-cyanoethanoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-2-yl]amino]-~{N}-ethyl-benzamide
Formula	C₂₁ H₂₃ N₇ O₂
Molecular Weight	405.453
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	N4(c1nc(ncc1)Nc2ccc(cc2)C(=O)NCC)C3CN(C(C3)C4)C(CC#N)=O
SMILES	CACTVS	3.385	CCNC(=O)c1ccc(Nc2nccc(n2)N3C[CH]4C[CH]3CN4C(=O)CC#N)cc1
SMILES	OpenEye OEToolkits	2.0.6	CCNC(=O)c1ccc(cc1)Nc2nccc(n2)N3CC4CC3CN4C(=O)CC#N
Canonical SMILES	CACTVS	3.385	CCNC(=O)c1ccc(Nc2nccc(n2)N3C[C@@H]4C[C@H]3CN4C(=O)CC#N)cc1
Canonical SMILES	OpenEye OEToolkits	2.0.6	CCNC(=O)c1ccc(cc1)Nc2nccc(n2)N3C[C@@H]4C[C@H]3CN4C(=O)CC#N
InChI	InChI	1.03	InChI=1S/C21H23N7O2/c1-2-23-20(30)14-3-5-15(6-4-14)25-21-24-10-8-18(26-21)27-12-17-11-16(27)13-28(17)19(29)7-9-22/h3-6,8,10,16-17H,2,7,11-13H2,1H3,(H,23,30)(H,24,25,26)/t16-,17-/m0/s1
InChIKey	InChI	1.03	YUJXKTRZTBIDCL-IRXDYDNUSA-N

Related Resource References

Resource Name	Reference
PubChem	134812674

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.